BioVectra is a forward-thinking North American CDMO with over 50 years of experience, offering services in clinical-to-commercial scale production of high-quality regulated APIs and intermediates. Their expertise lies in microbial fermentation, complex chemistry, and HPAPI process development, supporting partners' product development from clinical to commercial stages. With a focus on flexibility, creativity, and dedication to producing better therapeutics, BioVectra is committed to delivering quality products and managing client projects effectively.
Here are a few images about us. Please visit our website for more